Neutral impactResults

Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57%

Business Standard 1 hr ago·5 Nov 2026, 1:37 pm

Glenmark Pharmaceuticals' Q2FY27 net profit fell 56.8% to ₹263.83 crore, while revenue declined 29.8% to ₹4,247.32 crore, with earnings dragged by exceptional items.

Affected stocks

Neutral1 stock

Glenmark Pharmaceuticals

GLENMARK Neutral

₹2,504.70

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Glenmark Pharmaceuticals (GLENMARK).
  • Category: Results.

Why it matters

A routine update for Glenmark Pharmaceuticals. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at Business Standard.

More Company news

More news
Rashi Peripherals

Rashi Peripherals Limited — Outcome of Board Meeting

Rashi Peripherals₹867.05▲ 0.00%

NSE · 10 min ago

Healthcare Glob. ENT

Healthcare Global Enterprises Limited — Outcome of Board Meeting

Healthcare Glob. ENT₹610.90▲ 0.00%

NSE · 11 min ago

Ugro Capital

Ugro Capital Limited — Updates

Ugro Capital₹71.74▲ 0.00%

NSE · 11 min ago

Va Tech WABAG net profit up 18% at ₹104 crore

VA Tech Wabag₹1,865.60▲ 0.00%

BusinessLine · 11 min ago

Symbiotec Pharmalab

Symbiotec Pharmalab Limited — Outcome of Board Meeting

Symbiotec Pharmalab₹1,271.50▲ 0.00%

NSE · 12 min ago

Krishna Inst OF MED SCI L

Krishna Institute of Medical Sciences Limited — Analyst/Investor Meet Para A-XBRL

Krishna Inst OF MED SCI L₹731.05▲ 0.00%

NSE · 12 min ago

Ugro Capital

Ugro Capital Limited — Investor Presentation

Ugro Capital₹71.74▲ 0.00%

NSE · 12 min ago

FUSIONCX NSE

Fusion CX Limited — Agreements,Contracts,Arrangements,MOU-XBRL

Fusion CX₹278.20▲ 0.00%

NSE · 13 min ago

Kshitij Polyline

Kshitij Polyline Limited — Statement of deviation(s) or variation(s) under Reg. 32

Kshitij Polyline₹3.16▲ 0.00%

NSE · 13 min ago

Latest headlines

More news
Decillion Finance

Notice of Demand under Recovery Certificate number 9316 of 2026 dated November 05, 2026, issued to Manish Mishra (PAN:AMPPM6823L), Dipak Dwiwedi (PAN:ATDPD4055C), Vivek Chauhan (PAN:AHPPC9620A), Ankur Sharma (PAN:BMIPS3640D) and Neetu Dwivedi (PAN:CTTPD8770N) [Defaulters], jointly and severally, in the matter of Investigation in the trading activities of certain entities in the scrip of Decillion Finance Limited: under Recovery Certificate No. 9316 of 2026.

Decillion Finance₹34.00▲ 0.00%

SEBI · 9 min ago

Decillion Finance

Notice of Demand under Recovery Certificate number 9317 of 2026 dated November 05, 2026, issued to Manish Mishra (PAN: AMPPM6823L), Anshu Mishra (PAN: BMIPS3480H), Dipak Dwiwedi (PAN: ATDPD4055C), Vivek Chauhan (PAN: AHPPC9620A), Ankur Sharma (PAN: BMIPS3640D), Abhay Dwivedi (PAN: CWYPD8949K), Neetu Dwivedi (PAN: CTTPD8770N), Pallavi (PAN: BRTPP3401M), and Amrit Pal Singh (PAN: DTMPS0895B), [Defaulters], jointly and severally, in the matter of Decillion Finance Limited: under Recovery Certificate No. 9317 of 2026.

Decillion Finance₹34.00▲ 0.00%

SEBI · 9 min ago

Economy SEBI

Notice of Demand under Recovery Certificate number 9318 of 2026 dated November 05, 2026, issued to Priyanka Jain (PAN: BAZPJ9596E) [Defaulter], in the matter of Vedic Ayurveda Ltd (formerly known as KD Leisures Ltd.): under Recovery Certificate No. 9318 of 2026.

SEBI · 9 min ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.